ebola vaccine

The US Food and Drug Administration (FDA) for the first time approved the Ebola virus (EVD) vaccine for people 18 years of age and older.

The European Pharmaceutical Commission has approved the circulation of the world's first Ervebo vaccine (rVSV -G-ZEBOV-GP) to prevent Ebola.

According to TIME, the latest fatal case caused by the Ebola virus occurred at Iboko, the rural northwest region of Equateur province.

Although the initial results of this vaccine are very promising, changes related to new medical research regulations on primates can limit more intensive experiments.

Researchers have successfully developed the Ebola virus vaccine with efficacy of up to 100%.

It is expected that 300,000 doses of Ebola vaccine will be tested in May.

Medical experts identify, sex and masturbation may be hindering the exclusion of West African Ebola virus, due to the spread of this deadly pathogen through the survival of male

The clinical trial of an Ebola vaccine in Switzerland was suspended, after four patients complained of joint pain in their legs and arms.

A new Ebola vaccine has just been successfully developed in the United States. Human clinical trials show safe and positive results.

According to WHO experts, tens of thousands of people in West Africa will be able to test the Ebola vaccine early next year.